Skip to main content

Table 1 Population characteristics at baseline and comparison between patients with/without OHSI, and between OHSI patients and their paired controls

From: Early referral and control of disease’s flares prevent Orthopedic and Hand Surgery Indication (OHSI) in a dynamic cohort of Hispanic early rheumatoid arthritis patients

 

Population (N = 185)

Patients with OHSI (N = 12)

Patients without OHSI (N = 173)

OHSI-paired controls (N = 48)

p1

p2

Female sex, N° (%) of patients

162 (87.6)

11 (91.7)

151 (87.3)

44 (99.7)

1

1

(Mean ± SD) Age at cohort inclusion, years

38.5 ± 12.9

42 ± 15.6

38.3 ± 12.7

42 ± 14.9

0.33

1

Medium-low socioeconomic level, N° (%) of patients

165 (89.2)

11 (91.7)

154 (89)

43 (89.6)

1

1

(Mean ± SD) Years of formal education

11.2 ± 3.9

10.2 ± 4.3

11.3 ± 3.9

10.8 ± 4.2

0.32

0.66

Disease duration, months

5.3 (3. 3-7.0)

7.5 (6. 2-9.3)

5 (2. 9-7.4)

5 (2. 9-7.4)

0.02

0.02

N° (%) of patients with RF

152 (82.8)

11 (91.7)

141 (81.5)

44 (99)

0.7

1

N° (%) of patients with ACCP

158 (85.9)

12 (100)

146 (84.9)

43 (91.5)

0.22

0.6

N° (%) of patients with erosions

18 (9.7)

2 (16.7)

16 (9.2)

5 (10.4)

0.33

0.62

DAS28

5.9 (4.8-6.9)

7 (5.4-7.7)

6.3 (4.9-7.5)

6.3 (4.9-7.5)

0.27

0.27

Physician-VAS

36 (36–49)

51 (31-68)

41 (30-52)

41 (30-51.5)

0.23

0.23

CRP, mg/dL

0.7 (0.3-2.5)

3.6 (0.5-7.1)

1.2 (0.3-2.3)

1.2 (0.3-2.3)

0.06

0.06

ESR, mm/H

11 (12-39)

42 (19-74)

26 (15-49)

26 (15. 3-49)

0.14

0.14

Charlson Score

1 (1-1)

1 (1-1)

1 (1-1)

1 (1-1)

0.18

0.12

HAQ (0–3)

1.4 (0.9-2.1)

1.4 (1-2.3)

1.4 (0.9-2)

1.4 (0.9-2)

0.73

0.73

SF-36 (0–100)

38 (27-55)

33 (24-56)

34 (26-57)

33.8 (26.4-57.4)

0.94

0.94

Patient-overall disease-VAS

53 (33-76)

71 (41–92)

62 (34-78)

62 (34-78)

0.29

0.29

Pain-VAS

50 (31-73)

61 (46–98)

52 (33-78)

52 (33.3-77.8)

0.48

0.48

N° (%) of patients with DMARDs

101 (54.6)

7 (58.3)

94 (54.3)

19 (39.6)

1

1

N° (%) of patients with corticosteroids

72 (38.9)

4 (33.3)

68 (39.3)

15 (31.3)

0.77

1

  1. OHSI orthopaedic and hand surgery indication, N number, SD standard deviation, RF rheumatoid factor, ACCP antibodies to cyclic citrullinated peptides, DAS disease activity score (28 joints evaluated), VAS visual analogue scale, CRP C reactive protein, ESR erythrocyte sedimentation rate, HAQ health assessment questionnaire, SF-36 short form 36, P1 Comparison between patients with vs. without OHSI, P2 Comparison between patients with OHSI vs. paired controls
  2. Data presented as median (25th–75th IQR) unless otherwise indicated